Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clinical trial NCT00354250 · COMPLETED

Trial details

NCT number: NCT00354250
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2006-05-01
Primary completion: 2007-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.